-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
C4 Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2019 to Q3 2024.
- C4 Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $3.58M, a 102% increase year-over-year.
- C4 Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $14.1M, a 136% increase year-over-year.
- C4 Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $7.82M, a 475% increase from 2022.
- C4 Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $1.36M.
- C4 Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.76M, a 73% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)